Haemonetics Corporation (HAE) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.55B |
| Enterprise Value | 3.53B |
| P/E Ratio | 52.82 |
| PEG Ratio | -1.41 |
| Price/Sales Ratio | 3.66 |
| Price/Book Ratio | 5.9 |
| Enterprise/Revenue | 4.36 |
| Enterprise/EBITDA | 22.57 |
| Fiscal Year | March 28, 2026 |
| Most Recent Quarter | June 27, 2026 |
| Profit Margin | 0.07 |
| Operating Margin | 0.18 |
| Return On Assets | 0.04 |
| Return On Equity | 0.11 |
| Revenue | 1.33B |
| Revenue/Share | 29.81 |
| Gross Profit | 743.59M |
| EBITDA | 312.45M |
| Net Income | 97.31M |
| Diluted EPS | 2.05 |
| Total Cash | 223.38M |
| Total Cash/Share | 4.92 |
| Total Debt | 1.17B |
| Total Debt/Equity | 1.4 |
| Current Ratio | 3.08 |
| Book Value Per Share | 18.45 |
| 52-Week Change | 93.01 |
| 52-Week High | 109.57 |
| 52-Week Low | 47.32 |
| Moving Average 50 Days | 81.85 |
| Moving Average 200 Days | 70.83 |
| Average Volume | 877,711 |
| Shares Outstanding | 45.45M |
| % Held by Institutions | 108.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | December 03, 2012 |